Skip to main content
Clinical Trials/CTRI/2022/12/048271
CTRI/2022/12/048271
Completed
未知

The objective of this study will be to evaluate efficacy of skin care formulation in terms of reduction in appearance of fine lines and wrinkles, density of dark spots, improvement in skin moisturization, skin firmness on healthy female subjects

Transformative Learning Solution Pvt Ltd0 sites30 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
Transformative Learning Solution Pvt Ltd
Enrollment
30
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
March 10, 2023
Last Updated
2 years ago
Study Type
Interventional

Investigators

Sponsor
Transformative Learning Solution Pvt Ltd

Eligibility Criteria

Inclusion Criteria

  • 1\)Indian Female subjects
  • 2\)Healthy subjects (no infectious and evolutive pathology which could make the subject vulnerable and stop the study, no pathology which could interfere with the study, no symptom in the process of an exploratory checkup)
  • 3\)Skin is healthy on the studied anatomic unit (free of eczema, wounds, inflammatory scar)
  • 4\)Having crows feet wrinkles, fine lines of grade 2 \- 4 \& Dark spots
  • 5\)Having loose skin(face, Neck and upper arms)

Exclusion Criteria

  • 1 Female subjects who are pregnant (determined by Urine pregnancy test) or breastfeeding or having stopped to breastfeed in the past three months
  • 2 Having refused to give her assent by not signing the consent form
  • 3 Taking part in another study liable to interfere with this study
  • 4 Being insulin\-dependent diabetic or non insulin\-dependent diabetic with a recent therapy (less than 6 months)
  • 5 Having a progressive asthma (either under treatment or last fit in the last 2 years)
  • 6 Being epileptic.
  • 7 Having non stabilized thyroid problems (requirement of a stabilized treatment for at least 6 months)
  • 8 Having cutaneous hypersensitivity
  • 9 Having a diagnosed or highly probable allergy to one or several compounds of the cosmetic products.
  • 10 Having known allergy to any of the Ingredient of the Test Product

Outcomes

Primary Outcomes

Not specified

Similar Trials